文献速递肝病

居家力量训练干预对肝硬化患者的多中心初步随机临床试验:STRIVE研究

A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
PubMed 文献 · Am J Gastroenterol · 2021-01-01

本研究开发了针对肝硬化患者身体功能的居家力量训练干预(STRIVE),并在3个中心进行初步随机试验以评估其安全性和有效性。STRIVE干预安全可行,但依从性低(仅14%坚持10-12周),且与生活质量显著改善相关。

要点

  • STRIVE居家力量训练在肝硬化患者中安全可行,无不良事件报告。
  • 12周后LFI变化两组差异无统计学意义(P=0.65)。
  • STRIVE组生活质量(CLDQ)改善,但组间差异边缘显著(P=0.09)。

核心结论

  • STRIVE居家力量训练在肝硬化患者中安全实施,但依从性低,对LFI改善有限,可能与生活质量改善相关。

研究设计与样本

  • 多中心初步随机临床试验,3个中心,成人肝硬化患者随机2:1接受12周STRIVE(30分钟力量训练视频加健康教练)或标准护理。

主要发现

  • 12周时STRIVE组LFI中位从3.8降至3.6(ΔLFI -0.1),标准护理组从3.7降至3.6(ΔLFI -0.1),组间差异P=0.65。
  • STRIVE组CLDQ评分从4.6升至5.2(ΔCLDQ 0.38),标准护理组无变化(4.2-4.2;ΔCLDQ -0.03),组间差异P=0.09。
  • 标准护理组1例患者死于出血;STRIVE组无不良事件报告。
  • 仅14%的STRIVE参与者坚持力量训练视频10-12周。

临床怎么用

  • STRIVE方案可安全用于肝硬化患者,但需提高依从性策略以优化效果。

局限性

  • 初步研究样本量小,依从性低,可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We developed the strength training intervention (STRIVE), a home-based exercise program targeting physical function in patients with cirrhosis. In this pilot study, we aimed to evaluate the safety and efficacy of STRIVE. METHODS: Eligible were adult patients with cirrhosis at 3 sites. Patients were randomized 2:1-12 weeks of STRIVE, a 30-minute strength training video plus a health coach or standard of care (SOC). Physical function and quality of life were assessed using the Liver Frailty Index (LFI) and Chronic Liver Disease Questionnaire (CLDQ), respectively. RESULTS: Fifty-eight and 25 were randomized to STRIVE and SOC arms, respectively: 43% women, median age was 61 years, MELDNa, Model for End-Stage Liver Disease Sodium was 14, and 54% were Child-Pugh B/C. Baseline characteristics were similar in the STRIVE vs SOC arms except for rates of hepatic encephalopathy (19 vs 36%). LFI @ 12 weeks was available in 43 STRIVE and 20 SOC participants. After 12 weeks, the median LFI improved from 3.8 to 3.6 (ΔLFI -0.1) in the STRIVE arm and 3.7 to 3.6 (ΔLFI -0.1) in the SOC arm (P = 0.65 for ΔLFI difference). CLDQ scores improved from 4.6 to 5.2 in STRIVE participants (ΔCLDQ 0.38) and did not change in SOC participants (4.2-4.2; ΔCLDQ -0.03) (P = 0.09 for ΔCLDQ difference). One patient died (SOC arm) of bleeding. Only 14% of STRIVE participants adhered to the strength training video for 10-12 weeks. No adverse events were reported by STRIVE participants. DISCUSSION: STRIVE, a home-based structured exercise program for patients with cirrhosis, was safely administered at 3 sites, but adherence was low. Although all participants showed minimal improvement in the LFI, STRIVE was associated with a substantial improvement in quality of life.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lai JC, Dodge JL, Kappus MR, et al. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol. 2021. PMID: 33982941. doi:10.14309/ajg.0000000000001113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。